Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction
NCT: NCT05048667 · COMPLETED
Brief Summary
The purpose of this research study is to evaluate whether the combination of Shock Wave Therapy (SWT) with Platelet Rich Plasma (PRP) is synergistic and can reverse the pathology of microvascular Erectile Dysfunction (ED) and enhance erectile function by improving vasodilation, and endothelial function
Frequently Asked Questions
What is Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction?
Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction is a clinical trial registered under NCT05048667. Current status: COMPLETED.
What is the status of NCT05048667?
The current status of NCT05048667 (Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction) is: COMPLETED.
When did Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction start?
Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction started on 2022-06-27.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.